We are live on ! Find out more
PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

1 hedge funds and large institutions have $66.7K invested in Pardes Biosciences, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 59 → 1 (-58)

100% less capital invested

Capital invested by funds: $63.9M → $66.7K (-$63.8M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 58

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-58
Holders Change %
-98.31%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
58
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FCMV
Foresite Capital Management V
California
-$19.6M
2
VS
VK Services
California
-$11.1M
3
LCM
Lynx1 Capital Management
Puerto Rico
-$7.06M
4
BCM
BML Capital Management
Indiana
-$6.86M
5
TCM
Tang Capital Management
California
-$3.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
26
Irenic Capital Management
New York
– -$88.2K -48,751 Closed
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
– -$86.3K -47,664 Closed
YIH
28
Y-Intercept (HK)
Hong Kong
– -$85.9K -47,469 Closed
JC
29
JBF Capital
Colorado
– -$79.6K -43,998 Closed
MPM
30
MBB Public Markets
Illinois
– -$71.3K -39,400 Closed
SFG
31
SVB Financial Group
Texas
– -$65K -35,923 Closed
JP Morgan Chase
32
JP Morgan Chase
New York
– -$61K -33,682 Closed
Northern Trust
33
Northern Trust
Illinois
– -$56.9K -31,442 Closed
JSC
34
Jackson Square Capital
California
– -$47.8K -26,396 Closed
Morgan Stanley
35
Morgan Stanley
New York
– -$44.4K -24,549 Closed
Jane Street
36
Jane Street
New York
– -$36.3K -20,076 Closed
Charles Schwab
37
Charles Schwab
California
– -$34.8K -19,235 Closed
HM
38
Harvest Management
New York
– -$24.3K -13,435 Closed
CSS
39
Cubist Systematic Strategies
Connecticut
– -$23.7K -13,120 Closed
Citadel Advisors
40
Citadel Advisors
Florida
– -$22.2K -12,262 Closed
Squarepoint
41
Squarepoint
New York
– -$22.1K -12,211 Closed
Bank of New York Mellon
42
Bank of New York Mellon
New York
– -$18.2K -10,080 Closed
Creative Planning
43
Creative Planning
Kansas
– -$18.1K -10,000 Closed
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
– -$10.6K -5,832 Closed
Russell Investments Group
45
Russell Investments Group
United Kingdom
– -$9.45K -5,219 Closed
PMEF
46
Point72 Middle East FZE
United Arab Emirates
– -$8.15K -4,501 Closed
Fidelity Investments
47
Fidelity Investments
Massachusetts
– -$7.57K -4,181 Closed
Bank of America
48
Bank of America
North Carolina
– -$5.64K -3,118 Closed
Federated Hermes
49
Federated Hermes
Pennsylvania
– -$4.84K -2,677 Closed
National Bank of Canada
50
National Bank of Canada
Quebec, Canada
– -$1.81K -1,000 Closed
1
2
3

PRDS Hedge Fund Activity: Q3 2023 in Review

1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Pardes Biosciences, Inc. Common Stock (PRDS) for Q3 2023, worth a combined $66.7K — down 100% from $63.9M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of PRDS and 0 opened new positions — a net loss of 58 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Foresite Capital Management V, exiting entirely with an estimated $19.6M sold.

  • 1 institutional investor held Pardes Biosciences, Inc. Common Stock (PRDS) as of Q3 2023, down from 59 in Q2 2023.
  • Funds reported $66.7K of Pardes Biosciences, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Pardes Biosciences, Inc. Common Stock positions in Q3 2023 and 58 closed out, a net change of -58 holders.
  • The largest Pardes Biosciences, Inc. Common Stock seller in Q3 2023 was Foresite Capital Management V, an estimated $19.6M sold.

Based on aggregated 13F filings for Q3 2023.